Kalsow Carolyn M, Reindel William T, Merchea Mohinder M, Bateman Kirk M, Barr Joseph T
Ocular Research Services, Mendon, NY, USA.
Clin Ophthalmol. 2013;7:1291-302. doi: 10.2147/OPTH.S44642. Epub 2013 Jun 28.
An increased risk of corneal infiltrative events has been noted with the use of certain contact lenses and multipurpose solutions (MPS). This study was designed to evaluate tear cytokine assay as a sensitive, objective, and quantitative measure of the ocular surface response to contact lens/MPS and to consider the assay's clinical relevance in the context of other measures of ocular surface response.
Two MPS, ReNu® Fresh™ (RNF) and Opti-Free® RepleniSH (OFR), were used with daily wear silicone hydrogel contact lenses in a randomized, prospective crossover study involving 26 subjects. Clinical data collection (conjunctival hyperemia, ocular surface sensitivity, solution induced corneal staining (SICS) test score, and subjective responses) and tear cytokine assays were conducted masked. Responses were tracked as change from baseline throughout the experimental schedule.
SIMILAR RESPONSE PATTERNS FOR SEVERAL INFLAMMATORY CYTOKINES WERE SEEN THROUGHOUT BOTH PHASES: subjects who received OFR in Phase I had mean tear concentrations that were generally higher than those of the RNF Phase I group. OFR Phase I subjects had significant (P < 0.01) increases over baseline at day 1 and/or following washout for 13 cytokines (cc chemokine ligands [CCL] 3, CCL5, CCL11, granulocyte-macrophage colony-stimulating factor [GM-CSF], interferon [INF]-γ, interleukin [IL]-2, IL-4, IL-5, IL-6, IL-13, IL-15, IL-17, tumor necrosis factor [TNF]-α). These changes were not observed in RNF Phase I subjects, even though SICS test scores increased. Phase I OFR subjects also had increased dryness, while RNF Phase I subjects had decreased bulbar hyperemia. No changes were detected with respect to limbal hyperemia or surface sensitivity thresholds.
The tear cytokine assay can detect and differentiate contact lens/MPS induced increases in inflammatory cytokines. Changes in cytokine levels were consistent with measurement of hyperemia and dryness but not with SICS scores, thereby suggesting a proinflammatory response to OFR compared to RNF that is not related to SICS test score. Tear cytokine profiles may be useful for reconciling clinical relevance of test results and in revealing signaling involved in the development of corneal infiltrative events.
使用某些隐形眼镜和多功能护理液(MPS)时,角膜浸润事件的风险会增加。本研究旨在评估泪液细胞因子检测作为一种敏感、客观且定量的方法,用于衡量眼表对隐形眼镜/MPS的反应,并在眼表反应的其他衡量指标背景下考虑该检测方法的临床相关性。
在一项涉及26名受试者的随机、前瞻性交叉研究中,将两种MPS,即润明清新护理液(RNF)和傲滴恒润护理液(OFR),与日戴型硅水凝胶隐形眼镜一起使用。临床数据收集(结膜充血、眼表敏感度、护理液诱导的角膜染色(SICS)试验评分和主观反应)以及泪液细胞因子检测均在盲态下进行。在整个实验过程中,将反应追踪为相对于基线的变化。
在两个阶段中均观察到几种炎性细胞因子的相似反应模式:在第一阶段接受OFR的受试者,其平均泪液浓度通常高于RNF第一阶段组。OFR第一阶段的受试者在第1天和/或冲洗后,13种细胞因子(C-C趋化因子配体[CCL]3、CCL5、CCL11、粒细胞-巨噬细胞集落刺激因子[GM-CSF]、干扰素[INF]-γ、白细胞介素[IL]-2、IL-4、IL-5、IL-6、IL-13、IL-15、IL-17、肿瘤坏死因子[TNF]-α)相对于基线有显著(P<0.01)升高。在RNF第一阶段的受试者中未观察到这些变化,尽管SICS试验评分有所增加。第一阶段使用OFR的受试者干眼症状加重,而使用RNF的第一阶段受试者球结膜充血减轻。在角膜缘充血或表面敏感度阈值方面未检测到变化。
泪液细胞因子检测可以检测并区分隐形眼镜/MPS诱导的炎性细胞因子增加。细胞因子水平的变化与充血和干眼的测量结果一致,但与SICS评分不一致,这表明与RNF相比,OFR引发了一种与SICS试验评分无关的促炎反应。泪液细胞因子谱可能有助于协调检测结果的临床相关性,并揭示角膜浸润事件发生过程中涉及的信号传导。